Shawn Tomasello
CIK 1617239 · Chief Commercial Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$267.1K
Companies
10
Total Filings
51
Lifetime Open-Market Net
-$990.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CABA | Director | 22,725 | $3.01 | $68.4K | $50.3K | 6 | 2026-06-10 |
| FDMT | Director | — | $8.83 | — | $0 | 5 | 2025-06-20 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 70,000 | $9.81 | $686.7K | $0 | 4 | 2024-06-07 |
| Gamida Cell Ltd. (GMDA) Delisted | Director | 241,977 | $0.03 | $7.9K | $15.0K | 7 | 2024-02-02 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | — | $1.48 | — | $0 | 4 | 2023-06-01 |
| URGN | Director | — | $29.72 | — | $0 | 3 | 2021-06-09 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | — | — | — | $0 | 4 | 2020-09-28 |
| ABEO | Director | 35,938 | $5.53 | $198.7K | $0 | 1 | 2020-05-22 |
| Diplomat Pharmacy, Inc. (DPLO) Delisted | Director | 33,259 | — | — | -$51.1K | 8 | 2020-02-10 |
| Kite Pharma, Inc. (KITE) Delisted | Chief Commercial Officer | 61,068 | — | — | -$1.00M | 4 | 2017-09-27 |
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-25 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-31 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-10 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | URGN | Grant (A) | — | $0 | EDGAR |
| 2021-05-19 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2021-02-04 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-28 | Principia Biopharma Inc. (PRNB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2020-06-10 | URGN | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.